
|Articles|March 5, 2015
Interactive case 14: The case of the nighttime food thief
Advertisement
Advertisement
Possibly. Surgical removal and histologic examination of an adrenal mass is the ideal plan, but not every dog is a suitable surgical candidate and not every owner elects surgery. A discussion with the owner about why surgery is needed or recommended and whether the pet is a good candidate for surgery will need to occur. If surgery is not an option, treatment with mitotane can be considered in an effort to shrink the mass. These patients typically require higher starting doses (50 to 75 mg/kg/day) until cortisol concentrations are within the target range. Trilostane can also be considered as palliative therapy but will not affect the tumor.
Advertisement
Latest CE
Advertisement
Advertisement
Trending on dvm360
1
Federal judge dismisses Lincoln Memorial University's antitrust lawsuit against the AVMA
2
Paws and profits: Zoetis appoints global diagnostics president, NVA names chief medical officer, and more updates
3
As pets live longer, veterinarians see more cases of cognitive decline, Texas A&M expert says
4
When every second counts: Pharmacological and non-pharmacological interventions in RECOVER–guided emergency care for dogs and cats
5







